Biote (BTMD) Long-Term Investments (2021 - 2022)

Biote (BTMD) posted quarterly Long-Term Investments of $317.6 million for Q1 2022, little changed year-over-year from $317.5 million in Q1 2021, and little changed on a QoQ basis from $317.6 million in Q4 2021.

Biote (BTMD) Long-Term Investments (2021 - 2022) Analysis & Trends

Biote (BTMD) has reported Long-Term Investments for 2 consecutive years, with $317.6 million the latest figure, recorded in Q1 2022.

  • In Q1 2022, Long-Term Investments changed 0.02% year-over-year to $317.6 million; the TTM figure through Mar 2022 stood at $317.6 million (changed 0.02% YoY), while the FY2021 annual figure was $317.6 million, changed N/A from the prior year.
  • Long-Term Investments came in at $317.6 million for Q1 2022 at Biote, roughly flat from $317.6 million in the prior quarter.
  • The five-year high for Long-Term Investments was $317.6 million in Q1 2022, with the low at $317.5 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn 387.00 Mn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 143.78 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 3.81 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 167.44 Mn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn -
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn -
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn -
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn -
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn -
10 Biote 5,970.00 2.82 Mn 30.95 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 317.58 Mn
Dec 31, 2021 317.58 Mn
Sep 30, 2021 317.55 Mn
Jun 30, 2021 317.51 Mn
Mar 31, 2021 317.51 Mn